(Q42154755)

17 October 2017

The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin (English)

1 reference

17 October 2017

1 reference

1 reference

Ofosu FA

1

1 reference

17 October 2017

Sie P

2

1 reference

17 October 2017

Modi GJ

3

1 reference

17 October 2017

Fernandez F

4

1 reference

17 October 2017

Buchanan MR

5

1 reference

17 October 2017

Blajchman MA

6

1 reference

17 October 2017

Boneu B

7

1 reference

17 October 2017

Hirsh J

8

1 reference

17 October 2017

language of work or name

English

0 references

publication date

1 April 1987

1 reference

17 October 2017

1 reference

17 October 2017

243

1 reference

17 October 2017

2

1 reference

17 October 2017

579-588

1 reference

Preparation and properties of bovine factor VIII (antihemophilic factor).

17 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1147894

The role of phospholipids and factor Va in the prothrombinase complex

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1147894

Assembly of the prothrombinase complex in the absence of prothrombin.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1147894

The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1147894

The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1147894

Natural anticoagulant mechanisms

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1147894

The anticoagulant mechanism of action of heparin in contact-activated plasma: inhibition of factor X activation

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1147894

The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1147894

Chemistry of the hemostatic mechanism and its relationship to the action of heparin

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1147894

Heparin with low affinity to antithrombin III inhibits the activation of prothrombin in normal plasma.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1147894

A simple rate law that describes the kinetics of the heparin-catalyzed reaction between antithrombin III and thrombin.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1147894

The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1147894

D-PHE-PRO-ARGCH2Cl-A selective affinity label for thrombin

17 August 2018

1 reference

12 December 2020

Interactions between heparin and factor Xa inhibition of prothrombin activation

1 reference

12 December 2020

Coordinate binding of factor Va and factor Xa to the unstimulated platelet

1 reference

12 December 2020

The inhibition by heparin of the intrinsic pathway activation of factor X in the absence of antithrombin-III

1 reference

12 December 2020

Prevention of postoperative thromboembolic complications. A prospective comparison between dextran 70, dihydroergotamine heparin and a sulphated polysaccharide

1 reference

12 December 2020

Cofactor dependence of factor Xa incorporation into the prothrombinase complex

1 reference

12 December 2020

Activation of factor X and prothrombin in antithrombin-III depleted plasma: the effects of heparin

1 reference

12 December 2020

The interaction of human coagulation factor Va with platelets

1 reference

12 December 2020

A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation

1 reference

12 December 2020

A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection

1 reference

12 December 2020

Effect of heparin on the inactivation rate of human factor XIa by antithrombin-III

1 reference

12 December 2020

Activation of heparin cofactor II by dermatan sulfate

1 reference

12 December 2020

Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways

1 reference

12 December 2020

Identification of heparin cofactor II as the principal plasma cofactor for the antithrombin activity of pentosan polysulphate (SP54)

1 reference

12 December 2020

The isolation of prothrombin, Factor IX and Factor X from human Factor IX concentrates

1 reference

12 December 2020

Effect of heparin on the inactivation rate of human activated factor XII by antithrombin III

1 reference

12 December 2020

Thrombin-catalyzed activation of single chain bovine factor V

1 reference

12 December 2020

Low-affinity heparin potentiates the action of high-affinity heparin oligosaccharides

1 reference

12 December 2020

Inhibition of thrombin-catalyzed reactions in blood coagulation and platelet activation by heparin fractions in the absence of antithrombin III

1 reference

12 December 2020

Identifiers

DOI

10.1042/BJ2430579

1 reference

17 October 2017

1 reference

17 October 2017

1 reference